Loading...

NW Bio’s CTO Presents at 2nd Immunotherapy of Cancer Conference, ITOC-2

2,747 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Mar 26, 2015

Dr. Marnix L. Bosch, Chief Technical Officer of Northwest Biotherapeutics, presents encouraging new data on DCVax-L "Informational Arm" patients, who were excluded from the trial for the reasons of suspected real or pseudo progression. March, 2015. Munich, Germany.

Comments are disabled for this video.
When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...